Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
UVU Bio logo — Enabling a thriving bioeconomy across Africa

UVU Bio

Enabling a thriving bioeconomy across Africa

Founded 2019 South Africa South Africa 43 employees Venture round Total: $250.00M Internet

General Information

Company Name UVU Bio
Founded Year 2019
Location South Africa South Africa
Employees 43
Industries Internet
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with UVU Bio. To contact UVU Bio, visit citi.org.za.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does UVU Bio compare?

A PDF of UVU Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting UVU Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About UVU Bio

Citi is a non-profit organization founded in 1998, with a mission to nurture and support the information technology sector in Cape Town, Western Cape. The company's slogan "Empowering the future through inclusive IT development and support in Cape Town for widespread employment and prosperity" exemplifies its commitment to fostering employment opportunities and economic prosperity through information technology for individuals from diverse backgrounds. Citi received a significant ZAR250.00M Venture Round investment on 16 April 2018, which signifies its potential for growth and impact in the Internet industry. With its focus on inclusive IT development and support, Citi stands as an attractive opportunity for investors looking to contribute to the empowerment and economic growth of the Cape Town community.

Business keywords: non-profit organization, information technology, employment, prosperity, Cape Town, Western Cape, inclusive development, economic empowerment, IT cluster, diversity, community support

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round ZAR250.00M -
16 Apr 2018

UVU Bio Alternatives & Competitors

View All Alternatives
UVU Bio vs
ZAKKI
ZAKKI Indonesia

Helping Others by Real Action

31 employees
Education, Information Technology
UVU Bio vs
Purposity
Purposity United States

Purposity is building the future of generosity.

Seed
9 employees
Internet
UVU Bio vs
Host Your Voice
Host Your Voice

Empowering the next generation of changemakers through free website development, hosting, and strate...

Non Equity Assistance
Advertising, Internet
View all alternatives

FAQ About UVU Bio

Enabling a thriving bioeconomy across Africa
UVU Bio was founded in 2019.
UVU Bio is headquartered in South Africa.
UVU Bio operates in Internet. Its work centres on non-profit organization, information technology, employment and prosperity.
UVU Bio has approximately 43 employees.
UVU Bio has completed 1 funding round, raising a total of $250.00M. The latest funding stage is Venture round.
Top alternatives and competitors to UVU Bio include ZAKKI, Purposity, Host Your Voice, Seed Out (Official), Wikimedia Deutschland e. V.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
UVU Bio and ZAKKI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for UVU Bio, https://bouncewatch.com/company/citi-2, updated 25 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout